Home LiteratureArticle Details
PMID: 8642251 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Mature T cell reactivity altered by peptide agonist that induces positive selection.

The Journal of experimental medicine ·Vol. 183 ·No. 3 ·1996-03-01 ·Pages 1093-104

Sebzda E, Kündig TM, Thomson CT, Aoki K, Mak SY, Mayer JP, Zamborelli T, Nathenson SG, Ohashi PS

Abstract

Recent studies have investigated how defined peptides influence T cell development. Using a T cell receptor-transgenic beta2-microglobulin-deficient model, we have examined T cell maturation in fetal thymic organ cultures in the presence of various peptides containing single-alanine substitutions of the strong peptide agonist, p33. Cocultivation with the peptide A4Y, which contains an altered T cell contact residue, resulted in efficient positive selection. Several in vitro assays demonstrated that A4Y was a moderate agonist relative to p33. Although A4Y promoted positive selection over a wide concentration range, high doses of this peptide could not induce clonal deletion. Thymocytes maturing in the presence of A4Y were no longer able to respond to A4Y, but could proliferate against p33. These studies demonstrate that (a) peptides that induce efficient positive selection at high concentrations are not exclusively antagonists; (b) some agonists do not promote clonal deletion; (c) positive selection requires a unique T cell receptor-peptide-major histocompatibility complex interaction; and (d) interactions with selecting peptides during T cell ontogeny may define the functional reactivity of mature T cells.

MeSH Terms
Amino Acid Sequence Animals Antibodies, Monoclonal Base Sequence Cell Division Crosses, Genetic Fetus Flow Cytometry Lymphocyte Activation Macrophages/immunology Mice Mice, Inbred C57BL Mice, Transgenic Molecular Sequence Data Organ Culture Techniques Peptides/pharmacology Receptors, Antigen, T-Cell/biosynthesis,genetics T-Lymphocytes/drug effects,immunology Thymus Gland/cytology,embryology,immunology beta 2-Microglobulin/deficiency
Chemicals
Antibodies, Monoclonal Peptides Receptors, Antigen, T-Cell beta 2-Microglobulin
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Sebzda E
Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Kündig T M
Thomson C T
Aoki K
Mak S Y
Mayer J P
Zamborelli T
Nathenson S G
Ohashi P S
References (63)
63 references, click to expand
  1. Distinct fates of self-specific T cells developing in irradiation bone marrow chimeras: clonal deletion, clonal anergy, or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymus.
    J Exp Med. 1990 Nov 1;172(5):1305-14 PMID: 2230645
  2. Positive selection of thymocytes.
    Annu Rev Immunol. 1995;13:93-126 PMID: 7612239
  3. Peripheral selection of the T cell repertoire.
    Science. 1991 Mar 8;251(4998):1225-8 PMID: 1900951
  4. Ligand thresholds at different stages of T cell development.
    Int Immunol. 1990;2(1):83-9 PMID: 2150922
  5. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function.
    Nature. 1991 Jun 6;351(6326):482-5 PMID: 1710780
  6. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.
    Science. 1991 May 31;252(5010):1308-10 PMID: 1833816
  7. A unified model for T cell antigen recognition and thymic selection of the T cell repertoire.
    J Theor Biol. 1991 Jul 21;151(2):169-92 PMID: 1943141
  8. Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling.
    J Immunol. 1992 Feb 15;148(4):1003-11 PMID: 1737923
  9. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor.
    Cell. 1992 Feb 21;68(4):625-34 PMID: 1739971
  10. Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny.
    J Exp Med. 1992 May 1;175(5):1277-83 PMID: 1533241
  11. In vivo and in vitro clonal deletion of double-positive thymocytes.
    J Exp Med. 1992 May 1;175(5):1307-16 PMID: 1314886
  12. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen.
    Int Immunol. 1992 May;4(5):581-90 PMID: 1627495
  13. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses.
    Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10365-9 PMID: 1438221
  14. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
    J Exp Med. 1993 Apr 1;177(4):1047-60 PMID: 8384651
  15. Thymus epithelium induces tissue-specific tolerance.
    J Exp Med. 1993 Apr 1;177(4):1153-64 PMID: 8459209
  16. Peptides naturally presented by MHC class I molecules.
    Annu Rev Immunol. 1993;11:213-44 PMID: 8476560
  17. Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture.
    J Exp Med. 1993 May 1;177(5):1469-73 PMID: 8478616
  18. T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.
    J Immunol. 1993 May 15;150(10):4277-83 PMID: 8482836
  19. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.
    Nature. 1993 May 13;363(6425):156-9 PMID: 8483498
  20. Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus.
    Cell. 1993 Jun 4;73(5):1041-9 PMID: 8500174
  21. The thymic microenvironment.
    Immunol Today. 1993 Sep;14(9):445-59 PMID: 8216723
  22. Cellular tolerance as a dynamic state of the adaptable lymphocyte.
    Immunol Rev. 1993 Jun;133:45-73 PMID: 8225370
  23. Positive selection of TcR alpha beta thymocytes: is cortical thymic epithelium an obligatory participant in the presentation of major histocompatibility complex protein?
    Immunol Rev. 1993 Oct;135:133-55 PMID: 8282311
  24. T cell receptor antagonist peptides induce positive selection.
    Cell. 1994 Jan 14;76(1):17-27 PMID: 8287475
  25. The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection.
    Cell. 1994 Jan 14;76(1):39-50 PMID: 7506996
  26. Positive selection of lymphocytes.
    Cell. 1994 Jan 28;76(2):219-28 PMID: 8293460
  27. Negative selection of lymphocytes.
    Cell. 1994 Jan 28;76(2):229-39 PMID: 8293461
  28. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.
    Immunol Today. 1993 Dec;14(12):602-9 PMID: 8305133
  29. Evidence for a differential avidity model of T cell selection in the thymus.
    Cell. 1994 Feb 25;76(4):651-63 PMID: 8124708
  30. Positive and negative thymocyte selection induced by different concentrations of a single peptide.
    Science. 1994 Mar 18;263(5153):1615-8 PMID: 8128249
  31. Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4057-61 PMID: 7909610
  32. Specificity and flexibility in thymic selection.
    Nature. 1994 Jun 30;369(6483):750-2 PMID: 8008067
  33. A differential-avidity model for T-cell selection.
    Immunol Today. 1994 Aug;15(8):362-6 PMID: 7916949
  34. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus.
    J Exp Med. 1994 Nov 1;180(5):1901-10 PMID: 7525843
  35. Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells.
    Immunity. 1995 Jul;3(1):79-86 PMID: 7621079
  36. Recognition of multiple peptide cores by a single T cell receptor.
    J Exp Med. 1995 Aug 1;182(2):531-9 PMID: 7629510
  37. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype.
    J Exp Med. 1984 Aug 1;160(2):452-71 PMID: 6206178
  38. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.
    Nature. 1984 Dec 6-12;312(5994):548-51 PMID: 6150440
  39. Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db.
    Proc Natl Acad Sci U S A. 1986 Oct;83(19):7447-51 PMID: 3532114
  40. Expression and functional significance of the J11d marker on mouse thymocytes.
    J Immunol. 1987 Apr 1;138(7):2013-8 PMID: 2435787
  41. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex.
    Nature. 1988 Mar 3;332(6159):35-40 PMID: 3126396
  42. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens.
    Nature. 1988 Mar 3;332(6159):40-5 PMID: 3126397
  43. T cell selection in the thymus.
    Immunol Rev. 1988 Jan;101:173-90 PMID: 3280468
  44. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.
    Nature. 1988 Jun 23;333(6175):742-6 PMID: 3260350
  45. Positive and negative selection of an antigen receptor on T cells in transgenic mice.
    Nature. 1988 Nov 3;336(6194):73-6 PMID: 3263574
  46. Association of class I major histocompatibility heavy and light chains induced by viral peptides.
    Nature. 1989 Aug 10;340(6233):443-8 PMID: 2666863
  47. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.
    Cell. 1989 Nov 17;59(4):603-14 PMID: 2555063
  48. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy.
    Cell. 1994 Dec 2;79(5):913-22 PMID: 8001128
  49. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists.
    Science. 1995 Jan 27;267(5197):515-8 PMID: 7824949
  50. Increase in positive selection of CD8+ T cells in TAP1-mutant mice by human beta 2-microglobulin transgene.
    J Exp Med. 1995 Feb 1;181(2):787-92 PMID: 7836931
  51. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.
    Nature. 1989 Nov 30;342(6249):559-61 PMID: 2573841
  52. A nondeletional mechanism of thymic self tolerance.
    Science. 1989 Nov 24;246(4933):1038-41 PMID: 2511629
  53. The effects of MHC gene dosage and allelic variation on T cell receptor selection.
    Cell. 1990 Mar 23;60(6):1043-53 PMID: 2317862
  54. Thymic epithelium tolerizes for histocompatibility antigens.
    Science. 1990 Mar 23;247(4949 Pt 1):1471-4 PMID: 2321009
  55. A role for clonal inactivation in T cell tolerance to Mls-1a.
    Nature. 1990 Jun 7;345(6275):540-2 PMID: 1971916
  56. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.
    Science. 1990 Jun 8;248(4960):1227-30 PMID: 2112266
  57. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo.
    Nature. 1990 Aug 16;346(6285):629-33 PMID: 1696684
  58. Immunological function of a defined T-cell population tolerized to low-affinity self antigens.
    Nature. 1995 Mar 2;374(6517):68-9 PMID: 7870174
  59. Thymic selection: two pathways to life and two to death.
    Immunity. 1994 Apr;1(1):3-6 PMID: 7889396
  60. Are MHC-bound peptides a nuisance for positive selection?
    Immunity. 1994 Dec;1(9):721-3 PMID: 7895161
  61. Ligands for the T-cell receptor: hard times for avidity models.
    Immunol Today. 1995 May;16(5):223-5 PMID: 7779252
  62. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands.
    Immunity. 1995 Jun;2(6):655-63 PMID: 7540944
  63. Tolerogenicity of thymic epithelium.
    Eur J Immunol. 1990 Nov;20(11):2525-8 PMID: 2123795
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1996-03-01
Pages
1093-104
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2192317
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com